Navigation Links
New Study Finds Slow Rate of Growth in Overall Medical Technology Prices
Date:2/13/2008

Highlights Competitive Nature of Industry

WASHINGTON, Feb. 13 /PRNewswire-USNewswire/ -- AdvaMed, the Advanced Medical Technology Association, today released an important new study that demonstrates the slow rate in growth in overall prices in the highly competitive medical technology sector.

The study's author, Roland Guy King, former chief actuary for Medicare and Medicaid, and Gerald F. Donahoe, found that medical technology is a relatively small and constant share of total national health expenditures (NHE).

"The report's findings are significant in light of recent comments by some suggesting policies to limit the diffusion of and access to advanced medical technology in response to cost pressures. Simply put, medical technology is part of the solution to managing health care expenses and limiting patient access to life-saving, life-enhancing technologies compromises patient health and may actually increase costs," said Edward J. Ludwig, Chairman, President and Chief Executive Officer, BD and Board Chairman, AdvaMed.

"The innovative and competitive nature of the medical technology sector benefits patients by providing continual improvements in care," said Michael A. Mussallem, Chairman and CEO, Edwards Lifesciences, Chairman, AdvaMed Board Committee on Payment and Healthcare Delivery, and AdvaMed's Board Chairman-Elect. "This study shows that there is also an economic benefit of competition due to the relatively slow rate of growth in overall industry prices."

"The report's findings are clear: the highly competitive medical device marketplace is working and delivering tremendous value both in patient care and in economic terms. Policies that stifle innovation, interfere in the marketplace or limit access to care threaten that success," said Stephen J. Ubl, president and CEO of AdvaMed.

In 2004, the latest year studied, spending on medical devices and in vitro diagnostics totaled $112 billion or 6 perce
'/>"/>

SOURCE AdvaMed
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Geisinger study: PTSD a medical warning sign for long-term health problems
2. Body image is stronger predictor of health than obesity, says Mailman School of PH study
3. Study garners unique mating photos of wild gorillas
4. A functional immune system can be derived from embryonic stem cells, preliminary study finds
5. Veterinary researchers study poultry virus as human cancer treatment
6. Iomai Study Shows Self-Applied Travelers Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
7. Swine flu monitoring needed for farm workers, study says
8. Doctors uncertain about approaches to care for heart failure patients, SLU study finds
9. Study finds patients with complex fibroadenomas can avoid surgery
10. Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema
11. Newly Published Study Demonstrates Return on Investment for Employee Wellness Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Three new interactive anatomy education app...ins expand health sciences learning opportunities ... Durham, NC (Vocus) November 27, 2009 -- Modali...WW), a division of Wolters Kluwer Health, today an...ation apps on the App Store. Clemente’s Anat...
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... Benton Communications announces a highly ef...for retailers struggling to make an economic recov...6, 2009 -- Flu fears is the type of challenge that...room, according to Dr. David Benton, business grow...s growth system – The Rfactor Intensive . ...
(Date:11/25/2009)...ALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,al...oilsandsoftwareandCalgaryScientificInc.,aleadingpr...dawebversionofAegis(TM)Breast4DAdvancedVisualizati...ttrulyzero-footprintWebclientbasedmedicalimagingof...atformallowsforzero-footprintaccess-requiringnosof...
(Date:11/25/2009)...ANCISCO, Nov. 25 The Bay Area Air ...s first Winter Spare the Air Aler...rning wood, manufactured firelogs or any other sol...till weather will contribute to unhealthy air qual...cer of the Air District. "We,re asking Bay Area re...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...g babies unattended in standard car safety seats c...ms//, according to a recent study. A study co...esearchers at the University of Auckland in New Ze...g of babies in car seats could narrow their upper ...
...le drug for multiple complaints like cholesterol, ...ng designed at Dr Reddy’s the Hyderabad-based labo...e up with a combination of four drugs — a choleste...troke by 60 per cent. It will be available in the ...
... find a combination of healthy and tasty when we d... us any option of low calorie foods//. Mostly...ies we consume each meal, as we depend on the chef...e are becoming more health conscious. At the same ...
...breast cancer patients who are still young, and ha...ait for the stipulated //two years, post-treatment... Previously, young breast cancer patients wer...ersity of Western Australia said, 'For women with ...
... cancer screening has proven helpful to abort almo...ever researchers opine that such //screening unnec...adiation. NHS offers regular screening tests ... women under the age of 50 as well, it would poten...
...y conducted by Minnesota students have revealed th...ng themselves daily are more prone to develop eati...ealthy crash diets. In spite of dieting, they end ...it, and use diet pills in order to lose weight. Pr...
Other Medicine News:Health News:Poly-pill – A Single Drug For Multiple Complaint 2Health News:Are You Health-Conscious or Tongue- Conscious? 2
(Date:11/27/2009)... -- At the upcoming Radiological Society of North ...al Philips Electronics ( PHG, AEX: PHI) will demon...matics solutions designed to directly address the ...vering meaningful imaging innovations that reflect... upgradability. This focus will enable Philips to...
(Date:11/25/2009)...RNewswire/ -- Praxis Electronic Medical Records re...y of Family Physicians, (AAFP) Family Practice Man...r improving medical quality, health maintenance, a...timulus legislation. Praxis also ranked #1 among d...in determining their salary. Finally, Praxis also ...
(Date:11/25/2009)...wswire-FirstCall/ -- Heska Corporation ( HSKA); ("...ic and specialty products to the veterinary indust...ics Corporation for the supply of blood gas produc...arket. ,, (Logo: http://www.newscom.com/cg...oche share the same passion for innovating in the ...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 1Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 2Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 3Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 4IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 1IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 2
...iation Scientific Sessions ...7 Nabi,Biopharmaceuticals (Nasdaq: NABI ) today ...b trial of NicVAX(R) (Nicotine Conjugate Vaccine),...ational vaccine being,developed to treat nicotine ...2-month data confirm the highly significant trends...
...i Pasteur, the vaccines division of sanofi-aventis...e II testing of its cell culture-based,seasonal in...se I was announced on Sept 25, 2006. This project,...Department of Health and,Human Services (HHS) aime...lture- based influenza vaccine. Phase II trials in...
Other Medicine Technology:Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 7Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 2Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 3Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 4
Cottle Septum Elevator
Gillies Zygoma Elevator
Converse Periosteal Elevator
Converse-McKenty Periosteal Elevator
Medicine Products: